Levi & Korsinsky announces the commencement of a class action lawsuit in the USDC for the Southern District of Florida on behalf of shareholders of TherapeuticsMD, Inc. (NYSEMKT : TXMD) who purchased shares between July 7, 2016 and May 7, 2017.
The complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
If you suffered a loss in TherapeuticsMD, Inc. you have until June 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.